Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD)

International Journal of COPD

Volumn 8, Issue , 2013, Pages 389-395

  Yu, Wai Cho ^a   Fu, Sau Nga ^b   Tai, Emily Lai Bun ^c   Yeung, Yiu Cheong ^a   Kwong, Kwok Chu ^a   Chang, Yui ^a   Tam, Cheuk Ming ^c   Yiu, Yuk Kwan ^b  

^a PRINCESS MARGARET HOSPITAL   (Hong Kong)

^b Hospital Authority   (Hong Kong)

^c DEPARTMENT OF HEALTH   (Hong Kong)

Author keywords

Guidelines; Pulmonary function tests; Specialist

Indexed keywords

AGE; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PATIENT SELECTION; PREDICTION; SMOKING HABIT; SPIROMETRY; WALKING;

GUIDELINES; PULMONARY FUNCTION TESTS; SPECIALIST;

AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; EDUCATION, MEDICAL, CONTINUING; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HONG KONG; HUMANS; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; VITAL CAPACITY;

EID: 84883212856     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S48659     Document Type: Article

References (30)

1. Global Initiative for Chronic Obstructive Lung Disease, Inc. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease-2013 update. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf. Accessed April 8, 2013.
2. World Health Organization [homepage on the Internet]. Burden of COPD. Geneva: World Health Organization. Available from: http://www.who.int/respiratory/copd/burden/en. Accessed June 27, 2013.
3. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765-773.
4. Chan-Yeung M, Lai CK, Chan KS, etal. The burden of lung disease in Hong Kong: a report from the Hong Kong Thoracic Society. Respirology. 2008;13 Suppl 4:S133-S165.
5. Ko FW, Woo J, Tam W, etal. Prevalence and risk factors of airflow obstruction in an elderly Chinese population. Eur Respir J. 2008;32(6): 1472-1478.
6. Lau AC, Ip MS, Lai CK, etal. Variability of the prevalence of undiagnosed airflow obstruction in smokers using different diagnostic criteria. Chest. 2008;133(1):42-48.
7. Hardie JA, Buist AS, Vollmer WM, etal. Risk of overdiagnosis of COPD in asymptomatic elderly nonsmokers. Eur Respir J. 2002;20(5): 1117-1122.
8. Cerveri I, Coriscico AG, Accoridini S, etal. Underestimation of airflow obstruction among young adults using FEV1/FVC, 70% as a fixed cutoff: a longitudinal evaluation of clinical and functional outcomes. Thorax. 2008;63(12):1040-1045.
9. Johannessen A, Lehmann S, Omenaas ER, etal. Postbronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med. 2006;173(12):1316-1325.
10. Qaseem A, Wilt TJ, Weinberger SE, etal. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179-191.
11. National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care-2010 update. Available from: http://guidance.nice.org.uk/CG101. Accessed April 8, 2013.
12. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986;133(1):14-20.
13. Burrows B. The course and prognosis of different types of chronic airflow limitation in a general population sample from Arizona: comparison with the Chicago "COPD" series. Am Rev Respir Dis. 1989;140(3 Pt 2):S92-S94.
14. Yu WC, Tai LB, Fu SN, etal. Treatment of patients with chronic obstructive pulmonary disease as practiced in a defined Hong Kong community: a cross-sectional pilot survey. Hong Kong Med J. 2011;17(4):306-314.
15. Miller MR, Hankinson J, Brusasco V, etal; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338.
16. Ip MS, Ko FW, Lau AC, etal. Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization. Chest. 2006;129(2):384-392.
17. Guyatt GH, Pugsley SO, Sullivan MJ, Thompson PJ, Berman L, Jones NJ. Effect of encouragement on walking test performance. Thorax. 1984;39:818-822.
18. Bestell JC, Paul EA, Garrod R, etal. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-586.
19. Arne M, Lisspers K, Stallberg B, etal. How often is diagnosis of COPD confirmed with spirometry? Respir Med. 2010;104(4):550-556.
20. Bourbeau J, Sebaldt RJ, Day A, etal. Practice patterns in the management of chronic obstructive pulmonary disease in primary care practice: the CAGE study. Can Respir J. 2008;15(1):13-19.
21. Zhong N, Wang C, Yao W, etal. Prevalence of chronic obstructive pulmonary disease in China: a large population-based survey. Am J Respir Crit Care Med. 2007;176(8):753-760.
22. Joo MJ, Lee TA, Weiss KB. Geographic variation of spirometry use in newly diagnosed COPD. Chest. 2008;134:38-45.
23. Lee TA, Bartle B, Weiss KB. Spirometry use in clinical practice following diagnosis of COPD. Chest. 2006;129:1509-1515.
24. Eaton T, Withy S, Garrett JE, etal. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest. 1999;116:416-423.
25. Poels PJ, Schermer TR, Jacobs A, etal. Variation in spirometry utilization between trained general practitioners in practices equipped with a spirometer. Scand J Prim Health Care. 2006;24:81-87.
26. Bolton CE, Ionescu AA, Edwards PH, etal. Attaining a correct diagnosis of COPD in general practice. Respir Med. 2005;99:493-500.
27. Poels PJ, Schermer TR, Schellekens DP, etal. Impact of a spirometry expert system on general practitioners' decision making. Eur Respir J. 2008;31:84-92.
28. Damarla M, Celli BR, Mullerova HX, Pinto-Plata VM. Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respir Care. 2006;51(10):1120-1124.
29. Kaminsky DA, March TW, Bachand M, Irvin CG. Knowledge and use of office spirometry for the detection of chronic pulmonary disease by primary care physicians. Respir Care. 2005;50(12): 1639-1648.
30. Yawn BP, Enright PL, Lemanske RF Jr, etal. Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD. Chest. 2007;132(10):1162-1168.